HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Discovery of novel aromatase inhibitors using a homogeneous time-resolved fluorescence assay.

AbstractAIM:
Aromatase is an important target for drugs to treat hormone-dependent diseases, including breast cancer. The aim of this study was to develop a homogeneous time-resolved fluorescence (HTRF) aromatase assay suitable for high-throughput screening (HTS).
METHODS:
A 384-well aromatase HTRF assay was established, and used to screen about 7000 compounds from a compound library. Anti-proliferation activity of the hit was evaluated using alamarBlue(R) assay in a hormone-dependent breast cancer cell line T47D. Molecular docking was conducted to elucidate the binding mode of the hit using the Discovery Studio program.
RESULTS:
The Z' value and signal to background (S/B) ratio were 0.74 and 5.4, respectively. Among the 7000 compounds, 4 hits (XHN22, XHN26, XHN27 and triptoquinone A) were found to inhibit aromatase with IC50 values of 1.60±0.07, 2.76±0.24, 0.81±0.08 and 45.8±11.3 μmol /L, respectively. The hits XHN22, XHN26 and XHN27 shared the same chemical scaffold of 4-imidazolyl quinoline. Moreover, the most potent hit XHN27 at 10 and 50 μmol/L inhibited the proliferation of T47D cells by 45.3% and 35.2%, respectively. The docking study revealed that XHN27 docked within the active site of aromatase and might form a hydrogen bond and had a π-cation interaction with amino acid residues of the protein.
CONCLUSION:
XHN27, an imidazolyl quinoline derivative of flavonoid, is a potent aromatase inhibitor with anti-proliferation activity against breast cancer in vitro. The established assay can be used in HTS for discovering novel aromatase inhibitor.
AuthorsJin-zi Ji, Ke-jing Lao, Jie Hu, Tao Pang, Zhen-zhou Jiang, Hao-liang Yuan, Jing-shan Miao, Xin Chen, Shan-shan Ning, Hua Xiang, Yu-meng Guo, Ming Yan, Lu-yong Zhang
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 35 Issue 8 Pg. 1082-92 (Aug 2014) ISSN: 1745-7254 [Electronic] United States
PMID25047514 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aromatase Inhibitors
  • Flavonoids
  • Quinolines
  • Small Molecule Libraries
  • Aromatase
Topics
  • Aromatase (chemistry, metabolism)
  • Aromatase Inhibitors (chemistry, pharmacology)
  • Breast (drug effects, enzymology)
  • Breast Neoplasms (drug therapy, enzymology)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Drug Screening Assays, Antitumor (methods)
  • Female
  • Flavonoids (chemistry, pharmacology)
  • High-Throughput Screening Assays (methods)
  • Humans
  • Molecular Docking Simulation
  • Quinolines (chemistry, pharmacology)
  • Small Molecule Libraries (chemistry, pharmacology)
  • Spectrometry, Fluorescence (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: